Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
You Might Also Like
New Survey: 99 Percent of Executives Expect AI Layoffs Within 2 Years—What It Means for the Workforce
Executives are racing to cut costs and redesign work around AI, raising fears of a leaner workforce with fewer jobs.
0 Min Read
Why Gen Z is the Unexpected Lifeline for a Struggling Travel Industry
The U.S.-Iran war and other disruptive forces are undercutting expected 2026 travel sector growth, but changing tourism habits offer businesses…
0 Min Read
Bosses take remote less work seriously when it’s geared toward parents, study shows
Being penalized for using flexible working policies—remote work, hybrid work, parental leave, and more—can be subtle, or screamingly obvious. Nicole…
12 Min Read
Addiction, anxiety, and the attention economy
Conversations about youth mental health and addiction are often treated as separate issues—different experts, different headlines, different policy conversations. But…
4 Min Read
